EX-23.1 4 apre-20201231ex23158b415.htm EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

​

We consent to the incorporation by reference in the following Registration Statements:

| (1) | Registration Statement (Form S-8 No. 333-234765) pertaining to the 2019 Long Term Equity Incentive Plan of Aprea Therapeutics, Inc.,

| (2) | Registration Statement (Form S-8 No. 333-250043) pertaining to the 2019 Long Term Equity Incentive Plan of Aprea Therapeutics, Inc.,

| (3) | Registration Statement (Form S-3/A No. 333-250041) of Aprea Therapeutics, Inc.

​

of our reports dated March 16, 2021, with respect to the consolidated financial statements of Aprea Therapeutics, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2020.

​

​

/s/ Ernst & Young LLP

​

Iselin, New Jersey

March 16, 2021